122 results
424B5
WGS
GeneDx Holdings Corp - Ordinary Shares
30 Apr 24
Prospectus supplement for primary offering
4:26pm
takes any responsibility for, and can provide no assurance as to the reliability of, any other information others may give you. Neither we nor TD Cowen … , if any, are not determinable at this time. There can be no assurance that we will sell any shares under or fully utilize the Sales Agreement with TD
8-K
EX-1.1
WGS
GeneDx Holdings Corp - Ordinary Shares
29 Apr 24
Entry into a Material Definitive Agreement
5:10pm
expressly authorized to do so by the Company in a Placement Notice. The Company acknowledges and agrees that (i) there can be no assurance that TD
424B5
WGS
GeneDx Holdings Corp - Ordinary Shares
29 Apr 24
Prospectus supplement for primary offering
5:08pm
referred you. Neither we nor TD Cowen takes any responsibility for, and can provide no assurance as to the reliability of, any other information others … , if any, are not determinable at this time. There can be no assurance that we will sell any shares under or fully utilize the Sales Agreement with TD
8-K
EX-99.1
0t0mp bagykkp
29 Apr 24
GeneDx Reports First Quarter 2024 Financial Results and Business Highlights
4:09pm
8-K
EX-99.1
0lcc00odi9
20 Feb 24
GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024
4:28pm
8-K
EX-99.1
aec76d3 bzusj4h
8 Jan 24
GeneDx Announces Preliminary 2023 Financial Results
8:58am
8-K
EX-99.1
w7r4zt1 e7mcx2s29g
30 Oct 23
GeneDx Reports Third Quarter 2023 Financial Results and Business Highlights
4:33pm
8-K
EX-99.1
635i63qric36e3n6 fs
8 Aug 23
GeneDx Reports Second Quarter 2023 Financial Results and Business Highlights
4:13pm